Biotechnology Amgen Stock Adds Good Weight After CEO’s Update On Experimental Drug Rivaling Ozempic, Nixing Oral Weight-Loss Candidate – Amgen (NASDAQ:AMGN) Read more
Stockmarkets Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says Reuters via biedexmarkets.com Read more
Biotechnology Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly’s Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs – Agilent Technologies (NYSE:A), Avantor (NYSE:AVTR) Read more
Biotechnology Pharmaceutical Crime Jumps 50% As Criminals Seek To Capitalize Rising Tide of Counterfeit Weight-Loss Drugs – Novo Nordisk (NYSE:NVO) Read more
Cannabis Cannabis With Ozempic, Wegovy, Other Weight-Loss Drugs: Here’s What You Need To Know If You’re Combining Them – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Global Access to Weight-Loss Treatments: Indian Pharma Giants Eye Affordable Wegovy Alternatives Amid Rising Demand – Novo Nordisk (NYSE:NVO) Read more
Biotechnology The Skinny On Novo Nordisk: Weight-Loss Meds Make Big Pharma A Big Foe For Food Industry – Catalent (NYSE:CTLT), Chipotle Mexican Grill (NYSE:CMG) Read more
Biotechnology Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand – Catalent (NYSE:CTLT), Novo Nordisk (NYSE:NVO) Read more